Methods Mentioned
BETA
amputations
amputation
Clinical Trials Mentioned
NCT02173275
NCT01730534
NCT03594110
NCT03036150
NCT01986881
Software Mentioned
R
VERTIS
CREDENCE
CANTATA
CANVAS
Related Concepts
Related Feeds
Biomarkers for Cardiovascular Risk Assessment
Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.
CV Disorders & Type 2 Diabetes
This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.
Biomarkers for Type 2 Diabetes
Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.
Related Papers
International Journal of Clinical Practice
Paresh Dandona, Ajay Chaudhuri
Empagliflozin for Type 2 Diabetes Mellitus: An Overview of Phase 3 Clinical Trials
(opens in new tab)Current Diabetes Reviews
Matthew J Levine
The New England Journal of Medicine
Bruce NealCANVAS Program Collaborative Group
Critical Pathways in Cardiology
Sara Lee